ENTITY
CanariaBio

CanariaBio (016790 KS)

21
Analysis
Consumer StaplesSouth Korea
CANARIABIO Inc. operates as a new anticancer drugs development biotechnology company. The Company develops ovarian cancer, pancreatic cancer, gynecological cancer, and metastatic breast cancer immunotherapy drugs. CANARIABIO also produces sheep, pig, hog, poultry, and sweetened feed products.
more
27 May 2025 23:05

KRX Short Interest Weekly (May 23rd): Celltrion, Hanmi Semi, Meritz Financi

We analyzed KRX short interest report for the past week and highlighted short interest changes in Celltrion (068270 KS), Hanmi Semi (042700 KS),...

Logo
197 Views
Share
20 May 2025 23:05

KRX Short Interest Weekly (May 16th): Hanmi Semicon, Celltrion, Alteogen, Hanjinkal

We analyzed KRX short interest report for the past week and highlighted short interest changes in Hanmi Semicon (042700 KS), Celltrion (068270 KS),...

Logo
226 Views
Share
23 Apr 2024 19:42

Back Testing the End of Mandatory Lock-Up Periods Monthly Data in Korea

In this analysis, we provide a back testing analysis of the end of mandatory lock-up periods monthly data in Korea in the past six months....

Logo
965 Views
Share
08 Apr 2024 21:50

KOSDAQ150 Index Rebalance Preview: Potential Adds Still Outperforming

There could be 15 changes for the KOSDAQ150 Index in June. The potential adds have outperformed the potential deletes and the KOSDAQ150 Index over...

Logo
645 Views
Share
22 Mar 2024 19:42

Special Changes in KOSDAQ 150: Deletion (CanariaBio) + Addition  (C&C International)

On 22 March, the Korea Exchange announced special changes to KOSDAQ 150. CanariaBio will be excluded from KOSDAQ 150 and it will be replaced by C&C...

Logo
640 Views
Share
x